What Johnson Matthey (JMAT) Said on Its H1 Earnings Call

Johnson Matthey logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Johnson Matthey raised its 2026/27 underlying operating-profit growth outlook to high single digits from low-to-mid single digits. First-half sales rose 9% and underlying operating profit increased 32%, or 13% excluding metal-price effects and Cormetech.
  • Clean Air was the main growth driver: sales rose 10% to about £1.2 billion and operating profit increased 26%. The company also raised its Clean Power sales outlook to at least £250 million, citing U.S. data-center demand and a larger Cormetech order book.
  • First-half free cash flow was a £98 million outflow due to temporary refinery-related inventory buildup, which management expects to unwind in the second half. Full-year free cash flow is forecast to exceed last year’s £168 million, while the new U.K. refinery’s full ramp-up was pushed to early 2028.
  • Five stocks we like better than Johnson Matthey.

Johnson Matthey LON: JMAT raised its full-year profit outlook after stronger automotive demand and growth in its emissions-control business helped lift first-half sales and earnings.

The company now expects high single-digit growth in underlying operating profit for 2026/2027, up from its previous forecast of low to mid-single-digit growth. The guidance assumes constant currency and metal prices and excludes the effects of Catalyst Technologies, which Johnson Matthey sold, and its newly acquired Cormetech business.

Chief Executive Liam Condon said the performance reflected the company’s transformation, particularly improvements in Clean Air, its largest business. “The transformation at Johnson Matthey is translating into very tangible results,” he said.

Clean Air drives first-half growth

Group sales rose 9% in the first half, while underlying operating profit increased 32%, supported by higher metal prices, Chief Financial Officer Alastair Judge said. Excluding metal-price effects and Cormetech, underlying operating profit rose 13%.

Basic earnings per share increased 50% to £1.022, and the company raised its interim dividend by 3% to 22.7 pence per share, its first dividend increase in five years, according to Condon.

Clean Air sales rose 10% to about £1.2 billion, helped by a rebound in the U.S. Class 8 truck market and demand for emissions controls linked to data center expansion. Operating profit in the segment increased 26%, and its margin rose to 14.2% from 12.4%.

Judge reaffirmed the company’s 2027/2028 Clean Air guidance of at least £2 billion in revenue and a margin of 16% to 18%, excluding Cormetech. Condon said the company plans to report Clean Air Solutions separately as part of its new Clean Power business and will explain how the figures change when it does so.

In PGM Services, sales rose 6% to £239 million and operating profit increased 2% to £68 million. Hydrogen Technologies sales fell 26% to £17 million, but its operating loss narrowed to £3 million from £18 million a year earlier. Judge said the hydrogen business remains on track to break even at the operating-profit level and generate positive cash flow for the financial year.

Data center demand lifts Clean Power outlook

Johnson Matthey completed the sale of Catalyst Technologies to Honeywell in July and acquired Cormetech shortly afterward. It is combining Cormetech with its existing Clean Air Solutions operations to form Clean Power, which will be reported separately.

The company raised its full-year sales outlook for the combined business to at least £250 million from £200 million, with an operating margin of at least the mid-teens. The forecast includes eight months of Cormetech sales. Judge said the company expects Cormetech to contribute about £20 million in operating profit for the year.

Clean Air Solutions sales more than doubled to £59 million in the first half, while Cormetech contributed £33 million over two months. Both benefited from U.S. data center expansion, Judge said.

Condon said Cormetech’s order book through March 2028 had risen to £350 million from £300 million, with no cancellations or postponements. The company had turned away some customers because of capacity constraints, he said.

Asked about the risk that data center construction could eventually slow, Judge said new installations would flatten at some point, but the business also expects recurring revenue from servicing and replacing catalysts.

Cash flow and refinery timing

Johnson Matthey reported a first-half free cash outflow of £98 million, compared with an inflow of £4 million a year earlier. Judge attributed the outflow to a working-capital buildup associated with an additional stocktake at the company’s U.S. refinery, following an operational metal loss disclosed in May.

The plant was shut for three weeks for the stocktake, and inventory was built up beforehand to avoid disrupting customers. Judge said the working-capital buildup should unwind in the second half and that full-year free cash flow is expected to exceed the £168 million generated last year.

Separately, the company pushed the expected full ramp-up of its new U.K. refinery from calendar 2027 to early 2028. Condon said engineers recommended taking a few more months to improve the plant’s operation at full capacity. He said the change could involve modest additional capital spending but would not affect financial guidance or customer supply, which will continue from the existing refinery.

Net debt fell to £831 million from £880 million at the prior full year. The company has returned £800 million through a special dividend from the Catalyst Technologies sale proceeds and had completed about £72 million of a £200 million share buyback. It also reaffirmed its commitment to ongoing annual shareholder returns of at least £200 million.

About Johnson Matthey (LON:JMAT)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Johnson Matthey Right Now?

Before you consider Johnson Matthey, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.

While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines